EPHA2 and sarcoma: This exhaustion could potentially be reversed by equipping tumour‐infiltrating NK cells with enhancement‐of‐function genes such as a EphA2‐CAR and underscore the potential for developing a novel immunotherapeutic strategy for paediatric sarcomas.